Novel inflammatory-nutritional prognostic index for advanced gastric cancer patients undergoing gastrectomy and prophylactic hyperthermic intraperitoneal chemotherapy

doi:10.4240/wjgs.v17.i5.102201

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-4)

Tables (1-4)

Sum=0

May 27, 2025 (publication date) through May 23, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. May 27, 2025; 17(5): 102201
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.102201

Full Size Figure Download Figure

Figure 1 Inflammatory-nutritional prognostic index construction process and patient risk stratification. NLR: Neutrophil-to-lymphocyte ratio; PLR: Platelet-to-lymphocyte ratio; PAR: Platelet-to-albumin ratio; PNI: Prognostic nutritional index; SII: Systemic immune-inflammatory index; LMR: Lymphocyte-to-monocyte ratio; AGR: Albumin-to-globulin ratio; BMI: Body mass index; INPI: Inflammatory nutritional prognostic index.

Citation: Wang L, Chen MZ, Liu L, Jiang ZN, Zhang SM, Zhang MS, Zhang XX, Liu RQ, Wang DS. Novel inflammatory-nutritional prognostic index for advanced gastric cancer patients undergoing gastrectomy and prophylactic hyperthermic intraperitoneal chemotherapy. World J Gastrointest Surg 2025; 17(5): 102201
URL: https://www.wjgnet.com/1948-9366/full/v17/i5/102201.htm
DOI: https://dx.doi.org/10.4240/wjgs.v17.i5.102201